INSIGHTS ON QUALITY CONTROL

• Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity

  Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.

• Human Performance In Pharma: Strengthening The Biotech Workforce

  Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.

• Manufacturing Solutions

  Explore a cutting-edge service in powder blending, encapsulation, tablet compression, and on-site laboratory testing that meets the highest standards to ensure exceptional quality and compliance with cGMP regulations.

• A Closer Look At Multi-Lane Checkweighing In Pharma

  Learn how multi-lane checkweighing boosts operational efficiency, ensures accurate dosing, and simplifies changeovers, making it ideal for applications like dual-chamber sachets and nutraceutical products.

• CDMO Audit Coverage: Key Focus Areas And Compliance Objectives

  12/30/2025

  CDMO audits focus on compliance, quality, performance, and relationships to reduce risk, ensure clear documentation, and align customer expectations with CDMO capabilities.

• Essential Insights Into Pharmaceutical Product Release, Part 1 Of 2

  12/27/2024

  Pharma product release ensures drug quality, safety, and regulatory compliance by evaluating manufacturing and quality processes. It’s a critical, comprehensive process essential for FDA approval and patient safety.

• Compliance To Confidence: Annex 1 For Small-Batch, High-Value Production

  10/3/2025

  Get strategies for meeting the updated GMP Annex 1 in small-batch aseptic filling. Learn about contamination control, quality management, and equipment design for high-value liquid and powder products.

• Organ-Chips Outperform Animal Models And Spheroids

  8/2/2024

  Examine how 780 human Liver-Chips were assessed for their ability to predict drug-induced liver injury from small molecules.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  2/6/2026

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.